Heart failure associated with infiltrative cardiomyopathy in elderly patients.

Authors

  • Cristina Outón Servicio de Medicina Interna. Hospital Universitario Clínico San Carlos. Madrid. España
  • Fernando Tornero Servicio de Medicina Interna. Hospital Universitario Clínico San Carlos. Madrid. España
  • Marcos Fragiel Servicio de Medicina Interna. Hospital Universitario Clínico San Carlos. Madrid. España
  • Eva Orviz Servicio de Medicina Interna. Hospital Universitario Clínico San Carlos. Madrid. España
  • Manuel Méndez Servicio de Medicina Interna. Hospital Universitario Clínico San Carlos. Madrid. España

DOI:

https://doi.org/10.32818/reccmi.a3n1a9

Keywords:

amyloidosis, heart failure, restrictive cardiomyopathy.

Abstract

An 85-year-old man was referred to our hospital because of a first episode of heart failure. An echocardiography was performed, in which severe left ventricular hypertrophy was observed, more likely due to infiltrative myocardiopathy. With this clinical suspicion, a cardiac magnetic resonance was chosen to complete the study, both with result of likely cardiac amyloidosis. After these results, a genetic test was requested, with a negative result for transthyretin gene mutation, thus our patient was diagnosed as wild cardiac amyloidosis and was referred to Heart Failure Unit, where he remains clinically stable.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005; 112: 2047.

Maurer MS, Elliot P, Comenzo R, et al. Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis. Circulation. 2017; 135: 1357.

Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assesment, diagnosis, and referral. Heart. 2011; 97-75.

Chamarthi B, Dubrey SW, Cha K, et al. Features and prognosis of exertional syncope in lightchain associated AL cardiac amyloidosis. Am J Cardiol. 1997; 80(9): 1242

Selvanayagam JB, Harkins PN, Paul B, et al. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol. 2007; 50: 2101.

García-Pavía P, Tomé-Esteban MT, Rapezzi C. Amiloidosis. También una enfermedad cardiaca. Rev Esp Cardiol. 2011; 64: 797-808.

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016; 133(24): 2404-2412.

Raichlin E, Daly RC, Rosen CB, et al. Combined heart and liver transplantation: a single center experience. Transplantation. 2009; 88: 219.

Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol. 2016; 68: 1323-1341.

Published

2018-04-30

How to Cite

1.
Outón C, Tornero F, Fragiel M, Orviz E, Méndez M. Heart failure associated with infiltrative cardiomyopathy in elderly patients. Rev Esp Casos Clin Med Intern [Internet]. 2018 Apr. 30 [cited 2024 Dec. 26];3(1):25-8. Available from: https://www.reccmi.com/RECCMI/article/view/246